The short version
Only one company currently supplies this market — there is no backup if it stumbles. Historically, drugs in this position went on to a new shortage within 90 days about 0.4% of the time — roughly 3× the typical drug (0.1%).
Market view
glucagon · Injection, Powder, Lyophilized, For Solution
2 marketed package NDCs · 1 active manufacturer
Most dispensed: Kit · #1 kit/kit * 1 ml in 1 vial * 1 ml in 1 syringe · Kit · #1 kit/carton * 1 ml in 1 vial, glass * 1 ml in 1 syringe, glass · 3 mg · Powder · #1 tube/carton / 1 bottle, unit-dose in 1 tube / 1 powder in 1 bottle, unit-dose · Kit · #1 kit/carton * 1 ml in 1 vial * 1 ml in 1 syringe
What changed in the last 90 days
Every detected change for glucagon, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- GlucagonAug 19, 2026Price downNADAC $164.55308 → $160.531 per unit (-2.44%)
- GlucagonAug 19, 2026Price downNADAC $164.55308 → $160.531 per unit (-2.44%)
- GlucagonAug 19, 2026Price upNADAC $237.68333 → $239.20949 per unit (+0.64%)
- GlucagonAug 19, 2026Price downNADAC $164.55308 → $160.531 per unit (-2.44%)
- GlucagonAug 19, 2026Price downNADAC $164.55308 → $160.531 per unit (-2.44%)
- GlucagonJul 28, 2026New recallClass II · Lupin Pharmaceuticals Inc.
- GlucagonJul 25, 2026New productSportpharm LLC
- GlucagonJul 22, 2026Price downNADAC $165.09247 → $164.55308 per unit (-0.33%)
- GlucagonJul 22, 2026Price downNADAC $165.09247 → $164.55308 per unit (-0.33%)
- GlucagonJul 22, 2026Price downNADAC $239.27108 → $237.68333 per unit (-0.66%)
Same drug class
Other molecules FDA puts in Gastrointestinal Motility Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- asclepias vincetoxicum, echinacea (angustifolia), hypothalamus (suis), cerebrum (suis), hepar suis, kidney (suis), methylcobalamin, pancreas suis, stomach (suis), aacg-a, aacg-b, calcarea carbonica, gambogia, gelsemium sempervirens, graphites, nux vomica, phytolacca decandra, 7-keto (3-acetyl-7-oxo-dehydroepiandrosterone), adenosinum triphosphoricum dinatrum, glucagon, insulinum, sarcolacticum acidum, proteus (vulgaris)· 1 maker
- asclepias vincetoxicum, echinacea (angustifolia), hypothalamus suis, cerebrum suis, hepar suis, kidney (suis), methylcobalamin, pancreas suis, stomach (suis), aacg-a, aacg-b, calcarea carbonica, gambogia, gelsemium sempervirens, graphites, nux vomica, phytolacca decandra, 7-oxo-dehydroepiandrosterone-3beta-acetate (7-keto), adenosinum triphosphoricum dinatrum, glucagon, insulinum (suis), sarcolacticum acidum, proteus (vulgaris)· 1 maker
- glucagon injection· 1 maker
- glucagon injection, solution· 1 maker
Common questions
- Is Glucagon in shortage right now?
- No. FDA does not currently list Glucagon in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Glucagon?
- 13 companies have marketed Glucagon in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
- What does Glucagon cost?
- The typical pharmacy pays about $160.53 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.